Contact
      Please use this form to send email to PR contact of this press release:
      
      Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021
    
      TO:
      
      
      
      
      
      
      
    
      Please use this form to send email to PR contact of this press release:
      
      Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021
    
      TO: